Meet Strata

Next-generation precision oncology

Our mission is to accelerate the impact of precision medicine for patients with cancer.

About us 1

Every patient with cancer deserves our best

About us 2
Strata Icons Dark_Breaking Boundaries-Innovation
We are determined to eliminate barriers that stand between patients and their optimal outcomes

To achieve this, we work tirelessly with stakeholders across the healthcare ecosystem to make the promise of precision oncology a reality for as many patients as possible.

About us 3
We are driving a paradigm shift in cancer care, delivering smarter precision-matched treatment

We bring together leading-edge technology, real-world data and innovative clinical trials to optimize and expand the use of cancer therapies.

Everything we do is driven by our belief that advances in understanding the molecular underpinnings of cancer mean nothing until they become actionable for the physicians and patients we serve.

Our Leaders

Dan Rhodes, PhD
Dan Rhodes, PhD

Co-Founder & CEO

Scott Tomlins, MD, PhD
Scott Tomlins, MD, PhD

Co-founder & Chief Medical Officer

Matt Martin, MBA
Matt Martin, MBA

Chief Financial Officer

Catherine Sazdanoff
Catherine Sazdanoff

Chief Business Development Officer & Chief Compliance and Legal Officer

The company we keep

Board of Directors

Keith Flaherty, MD

Co-founder Strata Oncology, Professor, Harvard Medical School, Director of Clinical Research, Massachusetts General Hospital Cancer Center

Jan Garfinkle

Founder and Managing Partner, Arboretum Ventures

Michael Liang, PhD

Partner, Baird Capital

Chris O’Donnell, PhD

Partner and Executive Director, Pfizer Ventures

Dan Rhodes, PhD

President & CEO, Co-founder, Strata Oncology

Prem Tumkosit

Managing Director, Merck Global Health Innovation Fund, LLC Merck Global Health Innovation Group

Jeff Williams

Executive Chairman of the Board

Our Investors

Investor Logos=Wellington Management Logo Investor Logos=Cormorant Asset management Logo Investor Logos=Arboretum Logo Investor Logos=Merck Logo Investor Logos=HighSide Capital Managment Logo Investor Logos=Pfizer Logo Investor Logos=Monashee Investment Management Logo Investor Logos=Renaissance Venture Capital Logo Investor Logos=Deerfield Logo Investor Logos=Baird Capital Logo
Work for Strata Oncology

Join our team

Work for Strata Oncology

We are always looking for people that share our vision. Join us to create a new precision oncology, standard of care.

AICPA_SOC_21972-312_NonCPA_sm2

Strata Oncology has achieved SOC 2 compliance. This certification attests to the company’s commitment to protecting customer data and adhering to best practices in security and privacy infrastructure.

SOC 2 is a set of standards developed by the American Institute of Certified Public Accountants (AICPA) to provide customer assurance of a service provider’s system and operations. Compliance with these standards demonstrates that Strata Oncology has achieved the highest level of security, privacy, availability, and confidentiality for its services